Reaction
Congenital Cystic Kidney Disease reporting signals
As of the last recalculation, Congenital Cystic Kidney Disease appears in 843 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is MISOPROSTOL (PRR 38.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Misoprostol | 15 | 38.7 | 38.8 |
| Raltegravir | 23 | 35.3 | 35.4 |
| Zidovudine | 15 | 28.2 | 28.2 |
| Tolvaptan | 13 | 22.4 | 22.4 |
| Abacavir Sulfate | 7 | 17.9 | 17.9 |
| Darunavir | 10 | 16.5 | 16.5 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 5 | 13.8 | 13.8 |
| Nevirapine | 5 | 13.8 | 13.8 |
| Atazanavir | 7 | 12.1 | 12.1 |
| Sevelamer Carbonate | 5 | 10.8 | 10.8 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 16 | 8.8 | 8.8 |
| Paricalcitol | 5 | 8.8 | 8.8 |
| Agalsidase Beta | 3 | 8.0 | 8.0 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 6.7 | 6.7 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 6.6 | 6.6 |
| Cinacalcet Hydrochloride | 6 | 3.2 | 3.2 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 3.2 | 3.2 |